Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Tsuji

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|January 22, 2022
Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitorsKohei Tsuji, Takuya Kobayakawa, Kiju Konno, et al.
RSC Advances|March 23, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, et al.
European Journal of Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activityTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
ACS Infectious Diseases|May 21, 2024
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing AgentsTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
Biomolecules|February 6, 2021
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Frontiers in Microbiology|April 5, 2021
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC ActivatorsKouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, et al.
Journal of Medicinal Chemistry|September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl MoietiesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Chemical & Pharmaceutical Bulletin|December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond ReplacementKohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.
Chemical & Pharmaceutical Bulletin|January 3, 2024
Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
ACS Combinatorial Science|January 11, 2019
Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate ScaffoldsMegan Hogan, Medhanit Bahta, Kohei Tsuji, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|January 22, 2022
Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitorsKohei Tsuji, Takuya Kobayakawa, Kiju Konno, et al.
RSC Advances|March 23, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, et al.
European Journal of Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activityTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
ACS Infectious Diseases|May 21, 2024
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing AgentsTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
Biomolecules|February 6, 2021
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Frontiers in Microbiology|April 5, 2021
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC ActivatorsKouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, et al.
Journal of Medicinal Chemistry|September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl MoietiesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Chemical & Pharmaceutical Bulletin|December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond ReplacementKohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.
Chemical & Pharmaceutical Bulletin|January 3, 2024
Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
ACS Combinatorial Science|January 11, 2019
Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate ScaffoldsMegan Hogan, Medhanit Bahta, Kohei Tsuji, et al.
Pageof 7